RxDoctor Payments Data

Polly Moran, CNM

Advanced Practice Midwife · Bristol, CTNPI 1477656544

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 32.9% of the total. Reporting peaked in 2023 at $346 and has fallen 79.0% since, to $73 in 2025. Among advanced practice midwife clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,120in general payments, 2019–2025

Across 61 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$369
  • Therapeuticsmd, Inc.$160
  • Sumitomo Pharma America, Inc.$102
  • Exeltis, USA Inc.$94
  • Exact Sciences$74
  • Coopersurgical, Inc.$72
  • plus $250 from 9 others

What the payments were for

  • Food & beverage$1,120100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,120 in reported general payments places this provider in the 90th percentile of 129 advanced practice midwife providers in Connecticut.

See all advanced practice midwife providers in Connecticut

Medicare billing

Part B allowed, 2024
$5,412
Medicare patients
41
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
YuvafemEstradiol30$4,440
Estradiol43$2,400
ValacyclovirValacyclovir Hcl30$1,932
Betamethasone Dipropionate11$398
Amitriptyline Hcl18$367
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip21$232
Gabapentin14$177
Fluconazole15$54
Alprazolam19$28
Triamcinolone Acetonide15$25

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Bristol

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →